Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
Source: prnewswire.com